Resume

Gregor Wolbring, PhD.
Born: February, 12, 1962, Germany
Address: Dr. Gregor Wolbring, University of Calgary,
Dept of Community Health Sciences, Program of Community Rehabilitation and Disability Studies, Faculty of Medicine,
3330 Hospital Drive, NW, T2N 4N1,
Calgary, Alberta, Canada
Telephone: 1 (403) 686-6179 (res) 1 (403) 220-2985 (work)Fax: 1 (403) 283-4740 (work)

E-Mail: gwolbrin@ucalgary.ca
Webpage: http://www.bioethicsanddisability.org

Ableism and Ability Ethics and Governance blog: http://ableism.wordpress.com
Column The Choice is Yours: http://www.innovationwatch.com/commentary_choiceisyours.htm
NBICS Blog: http://wolbring.wordpress.com/

Interests:

Key Interests: Ability and ableism ethics and governance; History of thalidomide and thalidomiders; Social, ethical, legal, economic, environmental, cultural and governance issues of new, emerging and converging sciences and technologies (S&T) such as nanoscale S&T (feed, food, water…), molecular manufacturing, aging, longevity and immortality research, cognitive sciences, neuromorphic engineering, genetics, synthetic biology, bodily enhancement S&T, in vitro meat, artificial intelligence and robotics; Impact of S&T on: marginalized populations especially disabled people; Sports; human security, human right, personhood, sentient rights; concept of disability impairment, ableism and transhumanism; models and determinants of health; global health, tele-health, health- (technology assessment, law, care and policies); medical anthropology; foresight studies, bioethics issues, biochemistry, role of different stakeholders and evaluation of existing S&T discourses.

 

Education:

1982-1989

Diploma in Biochemistry at the University of Tübingen, Germany and University College London, England

1988

Diploma thesis at University College London, England and London Biotechnology Ltd. London, England about the development of a new non-radioactive detection system for gene probes

1989-1992

Ph.D. Thesis at the Max-Planck-Institute of Biophysics, Frankfurt a.M. and the University of Frankfurt a.M. Germany under the supervision of Prof. Hartmut Michel (Nobel Laureate), Germany

1992-1998

Post Doctoral Fellow at the University of Calgary, Faculty Dept. of Medical Biochemistry; Research

1998 - Present

Research scientist at the University of Calgary, Faculty of Medicine, Dept. of Medical Biochemistry; Research

Academic Appointments:

1999-

2002-2005

 2005-

 2007-

  2008-

Ethics, health research, governance of science and technology, ability-disability studies -related Career (biochemistry related career after this) (both careers were done at the same time till August 2008 when I gave up biochemistry):

Teaching: Courses developed and taught: All are online courses

2005-9 for Dept. of Community Rehabilitation and Disability Studies, University of Calgary 

2007 for Faculty of Law, University of Ottawa 

  1. CML –4104D – Studies in Public Law: Emerging Sciences and Technologies: Legal Ethics, Governance and Policy Discourse  (3 credits) Fall 2007

 

 

Journal Appointments:

  1. Guest Editor of a special issue “On the impact of nanoscale science and technology on disability, community and rehabilitation” for the International Journal of Disability, Community & Rehabilitation; Editor's Introduction to the IJDCR Special Issue on Nanotechnology, Disability, Community and Rehabilitation at  http://www.ijdcr.ca/VOL08_02/articles/editorial.shtml  Whole issue at  http://www.ijdcr.ca/VOL08_02/index.shtml
  2. Editorial Review Board of the new "International Journal of Nanotechnology and Molecular Computation" (IJNMC)
  3. Editor with Anita Ghai and Kirk Allison of a special issue of Journal: Review of Disability Studies with the theme Human Security, Social Cohesion and Disability: To be published August 2009
  4. Since 2008 member of the review board of the Journal: Review of Disability Studies Hawaii http://www.rds.hawaii.edu/ 
  5. Since December 2007 Member, International Editorial Advisory Board, Journal: Studies in Ethics, Law and Technology
  6. Co-editor special issue NanoBioInfoCogno and development Journal ‘Development’ published by the Society for International Development (SID) December (2006)
  7. Peer reviewer for the American Journal of Bioethics
  8. Peer Reviewer for the International Journal of Disability, Community & Rehabilitation
  9. Peer Reviewer for the Journal of Evolution and Technology

 Grants:

  1. (2005)  Successful. Collaborator, National Science Foundation. Nanotechnology and Society. Purpose: Establishment of a Centre for Nanotechnology and Society at Arizona State University.
  2. (2005) Successful: Principle Investigator, Health Technology Assessment Unit Alberta Heritage Foundation for Medical Research,. To write a background paper on the relationship between emerging technologies, imagery and situation of disabled people and the field of health technology assessment 
  3. (2008) Successful: Principal Investigator,  Alberta Ingenuity Grant
  4. (2009) Successful : SSHRC operating grant as Co-PI with Ian Kerr, University of Ottawa
  5. (2009)  Successful Genome Canada grant as Co-Investigator; PI: Gerrit Voordouw, University of Calgary

 

 Awards:

Membership on Boards, Committees and other Appointments:

 

  1. President Elect Canadian Disability Studies Association 2009/2010
  2. Member, Advisory Board of the Program in Human Rights and Health, School of Public Health, University of Minnesota, Minneapolis USA 2007-
  3. Member International Program Committee IASTED International Conference on Nanotechnology and Applications (NANA 2008),
  4. PACT senior research consultant for the Science & Technology Foresight directorate of the Office of the National Science Advisor, Government of Canada 2007-
  5. Chair Foresight Taskforce of the International Disability Caucus related to the UN Convention on the rights of persons with Disabilities 2007-
  6. Member of the Canadian Node of the UN Millenium Project 2006-
  7. Partner Conley International Canada, 2006-
  8. Senior Fellow, Oakland Institute, USA 2006-
  9. Member, Advisory committee World Report on Disability and Rehabilitation to be written by the World Health Organization (2006-)
  10. Member DALY Committee of Disabled People International (2006, work finished)
  11. Member, CAC/ISO - Canadian Advisory Committees for the International Organization for Standardization, section TC229 Nanotechnologies, 2005-
  12. Member, Steering Committee of the International research network on disability, health and wellbeing, launched 13 Sept 2005 in Mumbai, India, 2005-
  13. Member, International Nanotechnology and Society Network, 2005-
  14. Project Advisor, Research study titled, "Clinical Versus Experiential Views of Genetic Disability" This research is funded by the National Institutes of Health through the Ethical, Legal, and Social Issues program of the National Human Genome Research Institute (1 R01 HG 2422-01A2). Carol Gill Principal Investigator Associate Professor, Department of Disability & Human Development Director of Graduate Studies, Ph.D. Program in Disability Studies
    University of Illinois at Chicago (MC 626) . The Co-Investigators are: Adrienne Asch, Ph.D., Wellesley College; Kristi Kirschner, MD, Rehabilitation Institute of Chicago and Northwestern University; Kelly Ormond, Northwestern University, 2005-  
  15. Member, Canadian Coalition for Global Health Research, 2005-
  16. Member, Editor team of the Nanotechnology for Development portal of the Development Gateway Foundation, an independent not-for-profit organization conceived by former World Bank President, James Wolfensohn, 2005 –
  17. Scientific advisor, First international conference on water resources in the 21st century, 26-28th December 2005, Alexandria, Egypt,
  18. Chair, Bioethics taskforce of Disabled Peoples International, 2004-
  19. Abroad Advisor, Arab Healthy Water Association, 2004-2006 max term.
  20. Member, genetic technology advisory committee of the World Council of Churches, 2004-
  21. Member, Nano-health and Nano-ethics initiative of Canada, 2003-
  22. Member, Foothills Hospital Ethics Committee Calgary, Canada, 2003-
  23. Member, Advisory body of the Canadian Network for Inclusive Cultural Exchange, 2003-
  24. Member, Executive of the Canadian Commission for UNESCO, 2003-
  25. Member, Sectorial committee on Natural and Social Science of the Canadian Commission for UNESCO, 2003-
  26. Member, Board of ETC- Action Group on Erosion, Technology, and Concentration- formerly known as RAFI, 2002-
  27. Founding member, Collaborative on Health and the Environment, 2002-
  28. Founder of the virtual  International Center for Bioethics, Culture and Disability, 2002-
  29. Member, Canadian Commission for UNESCO, 2002-
  30. Member, Ethics working group of the Canadian Commission for UNESCO, 2001-
  31. Member, Board and Vice President, Canadian Center on Disability Studies,1999-2004
  32.  Member, Board of Director, Edmonds Institute, USA,1999-
  33. Founder and Coordinator, International network of bioethics and disability, 1999-
  34. Member, Board of The Alberta Provincial Health Ethics Network Canada, 1999-2005, (terms maxed out)
  35. Member, Canadian Delegation for the UNESCO and ICSU organized World Conference on Sciences Budapest (July 1999)
  36. Member, Human Rights Committee of the Council of Canadians with Disabilities (CCD), Canada, (1995-2004), and Bioethics advisor to the CCD, 1996-
  37.  Member, California Disability Alliance, 1996-
  38. Principle Investigator of the Thalidomide victim health research project at the University of Calgary, Canada (work finished).
  39. Scientific advisor, Thalidomide Victims Association of Canada, 1996-
  40. Co-founder, World Federation of Thalidomiders,1991
  41. Member, Disability Policy Committee, Faculty of Medicine, University of Calgary, Canada (finished)
  42. Member, Board of Directors, Thalidomide Society of Hessen, Germany, (1989-1992)
  43. Member, London Disability Arts Forum, UK, (1988-1992)
  44. Member, Board of Directors,  Assembly of Disabled People and Chair of the Bioethics and Transportation committees, Frankfurt, Germany, (1989-1992)

Publications:

Webpage/Column

 

 

 

My Students output

 

(My students, 2008) The E3LS issues of synthetic biology: Work done by three of my students Sibat Khwaja, Niklas Bobrovitz, Daniela Navia at iGEM 2008 http://2008.igem.org/Team:Calgary_Ethics 

E-Book, Peer Reviewed

 

  1. Wolbring (2007) Peer Reviewed The triangle of new and emerging technologies, disabled people and the World Council of Churches; Able-ism: A prerequisite for transhumanism, published as e-book by the World Council of Churches
  2. Wolbring (2006) Peer Reviewed A 220 page report. “The Triangle of Enhancement Medicine, Disabled People and the Concept of  Health: A new  challenge for HTA, health research and health policy” published by the Health Technology Initiative Publication Series  of the Health Technology Assessment Unit of the Alberta Heritage Foundation for Medical Research. Alberta, Canada

 

Chapters in Books

  1. Wolbring (2009) CRPD Ableism transhumanism and science and technology in U.N. Convention on Rights of Persons with Disabilities, Icfai University Press, India in print
  2. Wolbring (2008) Ableism, Enhancement Medicine and the techno poor disabled in Unnatural Selection: Challenges of Radical Life Extension and Enhancement Peter Healey and Steve Rayner Editor Publisher Earthscan
  3. Wolbring (2008) Monitoring Financial Flows for Health Research 2008 Prioritizing research for health equity; Box 2.1 Update on nanoscale science and technologies p 41-44 http://www.globalforumhealth.org/filesupld/MFF08/MonitoringFinancialFlows2008.pdf
  4. Wolbring (2008) Human Future: One World One Dream   Andy Miah, Mike Stubbs & Laura Sillarsin eds in Human Future Liverpool University Press http://humanfutures.fact.co.uk/   linked to the London 2012 Cultural Olympiad
  5. Wolbring (2008) Lego Atoms and Base pairs Sean Caulfield and Timothy Caulfied, eds, in Imagining Science (University of Alberta Press, http://www.uap.ualberta.ca/UAP.asp?LID=41&bookID=795).
  6. Wolbring (2008) The game is changing: Now is the time to act, Written for IDIRIYA in Sri Lanka: Topic is about the need and why it makes sense to built accessible infrastructure
  7. Wolbring (2008) Box Nanoscale sciences and technology and the framework of Ableism: in Nanotechnology: Ethics and Society CRC Press Editor Debra Bennett Wood
  8. Wolbring (2008) The Triangle of Disabled people, the concepts of cultural identity, cultural diversity, biological diversity, ableism and transhumanism and new and emerging sciences and technologies forthcoming Universidade de São Paulo Press EDUSP Cultural pluralism: Fourth volume of the collection Science, Scientists and Tolerance forthcoming.
  9. Wolbring (2006) The unenhanced underclass, Chapter 12 in Better Humans The politics of human enhancement and life extension Edited by Paul Miller James Wilsdon Publisher Demos Collection 21, Demos Institute, UK ISBN 1 84180 155 0
  10. Wolbring  and Kumar (2006),  'Volunteerism and disabled people' published by the Rehabilitation Council, India Editor, Mr Vedabhyas Kundu
  11. Wolbring (2005) A Disability Rights Approach to Eugenics, pp. 146-151 in “Rights and Liberties in the Biotech Age”, Council for responsible genetic (Ed), Rowman & Littlefield Publishing Group, ISBN, 0-7425-4341-2,
  12. Wolbring (2005) Disability Rights and Genetic Discrimination,  pp.178.183 in “Rights and Liberties in the Biotech Age”, Council for responsible genetic (Ed), Rowman & Littlefield Publishing Group, ISBN, 0-7425-4341-2,
  13. Wolbring (2004) Disability rights approach to genetic discrimination, pp. 161-184 in "Society and Genetic Information: Codes and Laws in the Genetic Era”, Judit Sandor (Ed) CPS books, Central European University Press, ISBN: 963924175X
  14. Wolbring (2004) Parents without Prejudice pp. 18-22 in "Reflections from a Different Journey: What Adults with Disabilities Want All Parents to Know" Stan Klein, John Kemp (Ed), McGraw Hill, ISBN: 0071422692
  15. Wolbring (2003) Confined to Your Legs pp. 139-157 in “Living with the Genie: Essays on Technology and the Quest for Human Mastery” A. Lightman, D. Sarewitz, and C. Desser (Eds.), Washington, DC: Island Press, ISBN: 1-55963-419-7
  16. Wolbring, et al (2003) Improving Human Health and physical Capabilities Theme C Summary pp. 159-162 in “Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science”, Mihail C. Roco, William Sims Bainbridge (Eds), Kluwer Academic Publishers, Dordrecht Hardbound, ISBN 1-4020-1254-3
  17. Wolbring (2003) Science and Technology and the triple D (Disease Disability Defect) pp. 206-215 in “Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science”, Mihail C. Roco, William Sims Bainbridge (Eds), Kluwer Academic Publishers, Dordrecht Hardbound, ISBN 1-4020-1254-3
  18. Wolbring and Golledge (2003) Improving Quality of Life of Disabled People using Converging Technologies pp. 240-243 in “Converging Technologies for Improving Human Performance: Nanotechnology, Biotechnology, Information Technology and Cognitive Science” Mihail C. Roco, William Sims Bainbridge (Eds), Kluwer Academic Publishers, Dordrecht Hardbound, ISBN 1-4020-1254-3
  19. Wolbring (2001) Where do we draw the line? Surviving eugenics in a technological world pp. 38-50 "Disability and the Life Course: global perspectives." Mark Priestley (Ed), Cambridge University Press, ISBN 0-521-79340-8

Peer-reviewed reports, articles in Peer-reviewed journals, academic conference proceedings

  1. Wolbring (2009) Nanoscale science and technology enabled transhumanization of health and related areas For (2) Daniel Lee Kleinman, Jason Delborne, Karen Cloud-Hansen, and Jo Handelsman (eds.), Controversies in Science and Technology, volume 3.  Leibert Publishers;
  2. Wolbring (2009) Nanoscale science and technology and social cohesion  for International Journal of Nanotechnology accepted
  3. Wolbring (2008) "Is there an end to out-able? Is there an end to the rat race for abilities?" for Journal: Media and Culture, Volume 11, Issue 3, http://journal.media-culture.org.au/index.php/mcjournal/article/viewArticle/57
  4. Wolbring (2008) Oscar Pistorius and the Future Nature of Olympic, Paralympic and Other Sports 5:1 SCRIPT-ed  pp.139-160 http://www.law.ed.ac.uk/ahrc/script-ed/vol5-1/wolbring.pdf  
  5. Wolbring, G and Saner, M (2008) Environmental Nanotechnology; Report for Environment Canada
  6. Wolbring (2008) Why NBIC? Why human performance enhancement? European Journal of Social Science Research, Vol 21,No.1,pp.25-40
  7. Wolbring (2007) Should we 'cure' aging? Studies in Ethics, Law, and Technology Vol 1 Issue 1
  8. Wolbring (2007) Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The changing face of biotech law? (Part I) Journal of International Biotechnology Law JIBL Vol. 4 Issue 4 September 177-186
  9. Wolbring (2007) Bio-tech, NanoBio-Tech, SynBio-tech, NanoSynBio-tech? The changing face of biotech law? (Part II) Journal of International Biotechnology Law JIBL Vol. 4 Issue 5 November 221-227
  10. Wolbring (2007) New and Emerging Sciences and Technologies, Ableism, Transhumanism and Religion, Faith, Theology and Churches in Madang; International Journal of Contextual Theology in East Asia, Volume 7 (June 2007) 79-112
  11. Wolbring (2007) What Convergence is in the Cards for Future Scientists? Conference paper online here
  12. Wolbring (2007) " Nano-engagement: For Whom? By Whom? With Whom? For What? What Risk? Medical Health? Environmental? Social? Accepted Journal of Health and Development (India)
  13. Wolbring (2007) Social and ethical issues of nanotechnologies ISO FOCUS the Journal of the International Organization for Standardtization ISO Focus, Volume 4, No. 4, April 2007, p.40-42. A full version of the article is online here, ISSN 1729-8709
  14. Wolbring (2006) 'Nanotechnology for health and development' in Development 49.4 New technologies and development published by Society for International Development
  15. Wolbring(2006) Last Word: The UN Convention on the rights of persons with disabilities Comments by Gregor Wolbring in Development 49.4 New technologies and development published by Society for International Development
  16. Wolbring (2006) "Emerging technologies (Nano, Bio, Info, Cogno) and the changing concepts of Health and disability/impairment:  A New Challenge for Health Policy, research and care" in Journal of Health and Development (India), Volume 2, Number 1&2, pp.19-37
  17. Wolbring (2006) Three challenges to the Ottawa spirit of health promotion, trends in global health, and disabled people (Commentary), September/October 2006 issue of the Canadian Journal of Public Health
  18. Wolbring (2006) A 220 page report. “The Triangle of Enhancement Medicine, Disabled People and the Concept of  Health: A new  challenge for HTA, health research and health policy” published by the Health Technology Initiative Publication Series  of the Health Technology Assessment Unit of the Alberta Heritage Foundation for Medical Research. Alberta, Canada
  19. Wolbring (2005) A Disability Rights Approach Towards Sex Selection in Development Volume 48 no 4 Special Issue on Sexual and Reproductive Health and Rights
  20. Wolbring (2004) “Disabled people's rights approach towards genetic discrimination” in Law and Human Genome Review Jul-Dec ;(21):165-84.
  21. Wolbring (2004) "Solutions follow perception: Nano-Bio-Info-Cogno-technology (NBIC) and the concept of health, medicine, disability and disease" in Alberta Health Law Review Volume 12, Number 3, pp.41-47
  22. Wolbring, G. (2003) “Disability rights approach towards bioethics” in Journal of Disability Policy Studies, 14(3), pp. 154-180
  23.  Wolbring (2003) “Social Construction of Health and Medicine” in Health Ethics Today, Vol. 13, Number 1, pp. 5-6
  24. Wolbring (2001) “Bioethics and Disability: Making Assumptions Explicit “in Health Ethics Today, Vol.12, No1, Fall 
  25. Wolbring (2001) “Disabled People's Approach to Bioethics” in American Journal of Bioethics Volume 1, Number 3, Page 1- 2
  26. Wolbring (2000) “Bio/gene technology and the disabled: The unheard voice” in Interaction, Vol. 13, Issue 3, pp. 25-31, published by the National Council on Intellectual Disability, Australia
  27. Wolbring (2000) “The disabled and the debate of bio/gene technology” in Bridges Vol. 8, Issue 2, Fall.  pp. 17-19published by the Vocational and Rehabilitation Research Institute, Canada.
  28. Wolbring (1998) “Illusion of Safety through Segregation” in In Touch, Vol.1, Nr.4, pp.1-2.

Encyclopedia contribution

  1. Wolbring 2009)  Thalidomide in   “Encyclopedia of American Disability History” New York: Facts on File
  2. Wolbring (2005) Science and Technology and Disabled People in "Encyclopedia of Science, Technology, and Ethics" Macmillan Reference, USA,

Small Monograph

  1. Wolbring (2006) Scoping paper on Nanotechnology on Nanotechnology and disabled people for the Center for Nanotechnology in Society, Arizona State University
  2. Wolbring,  Wetter, Yon-Bock, Kamaara, Lee, Robra (2006) Science, Faith & New Technologies: Transforming Life Volume I  Convergent technologies published by the Justice, Peace and Creation Team World Council of Churches & World Association for Christian Communication with Bossey Ecumenical Institute Authors
  3.  Wolbring et al (2006) Science, Faith & New Technologies: Transforming Life Volume II Science, Faith & New Technologies: Transforming Life Volume II Genetics, Agriculture and Human Life Discussion-Document by the Working Group on Genetic Engineering of the Justice, Peace and Creation Team World Council of Churches & World Association for Christian Communication produced by the Working Group on Genetic Engineering of the Justice, Peace and Creation Team of which I am a member
  4. Wolbring (2000)Science and the disadvantaged a 62 page booklet in the occasional papers series of the “Edmonds Institute,” USA.

Articles written for NGO’s and other non-academic groups

  1. Wolbring (2008) Synthetic Biology for Genewatch USA
  2. Wolbring (2008) A Constitution: A meta-governance tool for science and technology? for the group of people given the task to write the new Ecuadorian constitution
  3. Wolbring (2007) Nanofood for the Institute for Agriculture and Trade Policy IATP
  4. Wolbring (2008)  "Ability Studies: The Politics of Ableism." Development 51, 2. published by Society for International Development December
  5. Wolbring (2007) Glossary for the 21th Century
  6. Wolbring (2007) Disease Trading and Disease Intervention and Prevention Trading and Selling -- Kyoto Style for HealthWrights
  7.  Wolbring (2007) Editorial for HealthWrights NBICS With, For, and By the People: What it is, what it means and why it matters It is stored here as we had compatibility problems with healthwright software for the start of the article see Healthwright webpage
  8. Wolbring (2007) Nanofood to be published  by the Oakland Institute
  9. Wolbring (2006) New Challenges of Convergence of Advanced Technologies (NBICS) for Bioethical Policy" for a seminar for the Advanced Institute for Integral Study of Life (also available in Korean)
  10. Wolbring (2006) What technologies? A background paper for members of the national assembly of South Korea attending my workshop set up by Prof. Kim Yong-Bock and hosted by National Assembly Woman Yoo Seung Hee
  11. Wolbring (2006) Emerging science and technology policy issues: A background paper for members of the national assembly of South Korea attending my workshop set up by Prof. Kim Yong-Bock and hosted by National Assembly Woman Yoo Seung Hee (a short 17 pages executive summary also available in Korean)
  12. Wolbring (2006) Nanotechnologie, Behinderte und der ÖRK in Ökumenische Rundschau  October 2006 55. Jahrgang Heft 4 page 412-424
  13. Wolbring (2006) Things to come: nano-technology and HIV prevention in the magazine 'Contact', Number 182, August, 2006 Issue "HIV prevention: Current Issues and New Technologies" pp.38-39, World Council of Churches
  14. Wolbring (2006) "KEY TERMINOLOGIES IN THE FIELD OF DISABILITY: Impact on data, rehabilitation ‘health services’ and disabled people" for World Health Organization meeting on disability data and terminology in 27 and 28 July convened by the disability and rehabilitation unit of the WHO.
  15. Wolbring (2006)Transhumanization of ableism
  16. Wolbring (2006) The unenhanced underclass, Chapter 12 in Better Humans The politics of human enhancement and life extension Edited by Paul Miller James Wilsdon Publisher Demos Collection 21, Demos Institute, UK ISBN 1 84180 155 0
  17. Wolbring (2006) Nano Enhancement Medicine for special nanotechnology edition of FoE's Australia quarterly magazine Chain Reaction p35-37.
  18. Wolbring (2006) The unenhanced underclass reprint in the World Association for Christian Communication’s journal Media Development Issue 2006
  19. Wolbring (2006) Disabled people: A social group with cultural identities? in the World Association for Christian Communication’s journal Media Development special issue on Communication and cultural diversity Issue January 2006
  20. Wolbring (2006) Enhancement Medicine in "Ethicscorner" Publication of the Ethics committee of the Calgary Health Region, Canada
  21. Wolbring (2005) A Disability Rights Approach Towards Sex Selection in the special issue "Sexual and Reproductive Health and Rights" of the journal Development Volume 48 no 4
  22. Wolbring, G., (2005) Background paper for an online discussion on Sexual Violence against disabled people hosted by the WHO Sexual Violence Research Initiative.
  23. Wolbring (2005) Wolbring (2005) Rethinking the DALYs, for Forum 9 of the Global Forum for Health Research Mumbai, India 12 September 2005.
  24. Wolbring, G., (2004) Monitoring Financial Flows for Health Research 2004 Chapter 2 Highlight 2.2 Future shock? Flagging NBIC technologies pp. 28-30 published by the Global Forum for Health Research, Geneva, Switzerland
  25. Wolbring (2004) “A sustainable research and product development agenda?” On-line library of the Leadership Development department at The Banff Centre for the Arts, Banff, Canada
  26. Wolbring, G., West, R., and Campell, M., (2004) “Mind over Kitchen: The Future of Thought-controlled Personal Environments” in Horizon Zero 14.2”
  27. Wolbring (2004) “Universal Architectures: Gregor Wolbring on Nano-Bio-Info-Cogno (NBIC) convergence and the ethics of self-identity” in Horizon Zero 14.2
  28. Wolbring (2002) “The Silenced Target” written for the Institute of Science in Society UK
  29. Wolbring (2001) “Ciencia, tecnología y la DED (discapacidad, enfermedad, defecto)” Documento presentado en el Seminario "Nuevas Tecnologías: posiciones e imposiciones" realizado en Temuko, Región Mapuche entre el 27 y el 30 de noviembre de 2001 y organizado por ETC Group y CETSur
  30. Wolbring (2001) “Im Land der begrenzten Möglichkeiten (In the Land of limited Possibilities) Die Situation der Humangenetikdebatte in Nordamerika (The Situation of the human genetic debate in North America)” in Gene Ethischer Informationsdienst (GID), GID Spezial Nr.2 Dezember, Eugenik -Gestern und Heute, pp. 28-36, ISSN 0935-2481
  31. Wolbring (2000) “AIMS OF MEDICINE- NEW FRONTIERS IN MEDICINE Virtual Round Table New frontiers in medicine Genetics,” by Giuseppe Recchia Medical Director, Glaxo Wellcome, Italy
  32. Wolbring (2000) “The Writing is on the Wall” in Gene Watch, Vol.13, No.3, pp. 8-9
  33.  Wolbring (2000) “Bioethics and Disability,” for Philia A Dialogue on Citizenship Themes: Ethics and Community – Ideas 
  34. Wolbring (2000) “Animal Farm Philosophy” in Hadar Forum, No.1, pp.2-3, SWEDEN
  35. Wolbring (1999) “Eugenics, Euthenics, Euphenics’ in Gene Watch, Vol.12, No.3, pp. 8-10
  36. Wolbring (1999) “Do No Harm” in Gene Watch, Vol. 12, No.2, p 10.
  37. Wolbring (1998) “No problem with thalidomide” in The Ragged Edge, Sept/Oct p. 9
  38. Wolbring (1997) “Is Ableism a form of eugenics” in Transition, Aug/Sept, pp.12-18 publishedby BC Coalition of People with disabilities
  39. Wolbring and Sobsey (1997) “Sobsey and Wolbring Speak Out. Responding to Dying with Dignity” in Latimer Watch published by Council of Canadians with Disabilities;
  40. Wolbring and Sobsey (1996) “Violence and Abuse Child Abuse and Disability” in Rehabilitation Digest, Volume 26, Issue 3, pp. 11-14
  41. Wolbring (1996) “Euthanasia part II” in Action #13 published by Thalidomide Victims Association of Canada, Winter, pp. 12-17
  42. Wolbring (1996) “Euthanasia” in Action #12 published by Thalidomide Victims Association of Canada, Autumn, pp. 8-11
  43. Wolbring (1995) A Breech of Compassion in “A Voice of Our Own” Publication of the council of Canadians with disabilities pp. 5-8

 

Interventions/ briefing papers written for NGOs and others

  1. Wolbring (2005) Evaluation of the Biotech statements of the World Council of Churches in the light of the disability model put forward by the EDAN prepared for the World Council of Churches, internal document
  2. Wolbring (2004) Intervention on behalf of Disabled People International in regards to the UNESCO declaration on Universal Norms for bioethics third draft
  3. Wolbring (2004) Intervention on behalf of Disabled People International in regards to the UNESCO declaration on Universal Norms for bioethics second draft
  4. Wolbring (2003), Intervention on behalf of Disabled People International in regards to the UNESCO Report of the IBC on Pre-implantation Diagnosis and Germ-line Intervention
  5. Wolbring (2003), Intervention on behalf of Disabled people International in regards to the UNESCO Revised outline of the International Declaration on Human Genetic Data second version
  6. Wolbring (2003), Intervention on behalf of Disabled people International in regards to the UNESCO Provisional Preliminary Draft of the International Declaration on Human Genetic Data
  7. Wolbring (2002), Intervention on behalf of Disabled people International in regards to the UNESCO International Declaration on Human Genetic Data first version
  8. Wolbring (2002), Intervention on behalf of Disabled people International in regards to the UNESCO Universal Instrument on Bioethics first draft
  9. Wolbring (2002), Intervention on behalf of Disabled People International in regards to the UNESCO Draft Report on Pre-implantation Genetic Diagnosis and Germ-line Intervention
  10. Wolbring (2001) Expert opinion for the Study Commission on the Law and Ethics of Modern Medicine of the German Bundestag with the title "Folgen der Anwendung genetischer Diagnostik für behinderte Menschen" (Consequences of the application of genetic diagnostics for disabled people) http://www.bundestag.de/parlament/kommissionen/archiv14/medi/medi_gut_wol.pdf
  11. Wolbring (1999) Thalidomide survivors; a questionnaire survey on musculoskeletal abnormalities, general health, and quality of life.
  12. Wolbring (1998) Why Disability Rights Movements Do Not Support Euthanasia) for the Council of Canadians with Disabilities
  13. Wolbring (1998) Renewal of Canadian Biotechnology Strategy 1998 written for the Council of Canadians with Disabilities and presented to Health Canada
  14. Wolbring and Sobsey 1995 Euthanasia, Assisted Suicide, & People with Disabilities a Background Paper Prepared for the Premier's Council on the Status of Persons with Disabilities (Alberta)

Writings about me

  1. Winter 2006 Reaction; Newsletter for members of the thalidomide Victims Association of Canada: item 1) Title A beautiful Poem about me Gregors Poem by Jim Thomas Item 2) The Chosen Ones June 2nd Stuart Laidlaw the Toronto Star Item 3) About Gregor Wolbring by Mercedes Benegbi
  2. Interview with The Collaborative on Health and the Environment (CHE) Partner, Dr. Gregor Wolbring http://www.healthandenvironment.org/articles/homepage/760
  3. The Canadian Embassy in Sao Paulo Brasil, advertised a lecture by Dr. Wolbring in Brasil Professor canadense participa do Seminário Internacional sobre Bioética, Deficiência e Direitos Humanos http://www.dfait-maeci.gc.ca/brazil/professor_canadense-pt.asp
  4. Nano bio in society 2006 addresses social safety of nanotechnology http://www.nanotechbuzz.com/50226711/nano_bio_in_society_2006_addresses_social_safety_of_nanotechnology.php
  5. The World Knowledge Library http://www.masterliness.com/a/Gregor.Wolbring.htm
  6. (2004) WORLDWIDE FOOD THREAT  http://www.manataka.org/page525.html
  7. (2004) *Finally, A Book to Help Parents of Disabled* by Helen Henderson /Reprinted courtesy of Torstar Syndication Services from the /Toronto Star/, April 17, 2004./ http://www.nfb.org/fr/fr17/fr05ws20.htm
  8. (2004) “Gregor's Poem” A Poem about me by Jim Thomas
  9. (2004) Serebella: Encyclopedia index: Sub-index 1: Sub-index 2 http://www.serebella.com/encyclopedia/article-Gregor_Wolbring.html
  10. (2004) "In Profile Gregor Wolbring an Ardent advocate" by Lynne Swanson in Abilities Magazine, Issue 60, Fall, pp. 14-15
  11. (2003) “Nanotechnology: Tiny Science, Huge Threat the nano-world is exploding, but some would shrink the debate as small as the science” by Cascadia Media Collective http://www.cascadiamedia.org/commentary_nano.html
  12. (2003) Nanotech: small science, huge threat by Cascadia Media Collective Monday July 21, 2003 at 09:07 PM  http://italy.indymedia.org/news/2003/07/337620.php
  13. (2003) “Not a Man to Mess With An activist in the struggle against euthanasia is not a man to mess with”, by Sue Careless at <http://www.christianity.ca/news/social-issues/2003/06.000.html>
  14. (2001) “Reconciling Science and Society”, Tanya Williams, Scott Siera, and Arri Eisen, The Journal of Philosophy, Science & Law Volume 1, December http://www.psljournal.com/archives/newsedit/recon_science2.cfm
  15. (1999) “Canadian biochemist places disabled's fate firmly on the table” 1 July, in Nature News http://www.nature.com/wcs/2diary/01-2a.html
  16. Drafting group weathers the storm 1 July, in Nature News  http://www.nature.com/wcs/1news/01-1a.html
  17. (1999) “Canadian biochemist puts disability on agenda” in: Equality matters published by Council of Canadians with Disabilities http://www.ccdonline.ca/publications/equality-matters/0300.htm
  18. Disabled seek input on bioethics: Breaking Down Barriers/The Toronto Star/, Saturday, October 23, 1999 /by Helen Henderson / http://www.ccdonline.ca/issues/bioethics/1099.htm
  19. (1996) “Why a cripple wants to live”, The Canberra Times Australia p1-2 Wed. Oct. 30th by Marion Frith
  20. (1994) “Any law would lead to abuse: An assisted suicide opponent points to perils in legalization”. British Columbia Report, November 14, p. 23

 

Other

  1. (2004) report “Nanoscience and nanotechnologies: opportunities and uncertainties” by the Royal Society and Royal Academy of Engineering refers to my thoughts on Nanotechnology http://www.nanotec.org.uk/finalReport.htm
  2.  Wolbring (2004) the Atlantic | July/August 2004 | Letters to the Editors
  3. Wolbring (2004) The Independent on Sunday Letter to the Editors 18 July responding to a suggestions that Prince Charles sees Nanotechnology behaving like thalidomide
  4. (2004) “Immense Risk' As 200 Firms Using Nanotech In Food” By Geoffrey Lean, Environment Editor, The Independent, UK - 18 July http://www.sirianrevelations.net/testi/nanotech_food.shtml
  5. (2003) “No Freak’ by Anthony Thanasayan, Wheel Power Columnist Thursday, July 31, the Star Malaysian Newspaper
  6. (2002) “The here and now” By Anthony Thanasayan Wheel Power Columnist Thursday, September 19, 2002 the Star Malaysian Newspaper
  7. (2001) “Eugenics on trial Affirmative Action Human rights challenged in France” Posted 01-24-2002, 18:44 by Peter Ladwein in Northwestern Chronicle
  8. (2001 Speaking Notes for The Honourable Dr. Gilbert Normand Secretary of State (Science, Research and Development) On the Occasion of the
    UNESCO General Conference Paris, France October 23, 2001 I would also like to note the participation at that conference of the eminent Canadian biochemist, Dr. Gregor Wolbring, founder of the International Network on Bioethics and Disability. The network was created by Professor Wolbring to facilitate the inclusion of persons with disabilities in the debate, as well as their participation in the decision-making process, which, I'm sure we will all agree, meets another need. <http://www.ic.gc.ca/cmb/welcomeic.nsf/0/85256a220056c2a485256aee00487d41?OpenDocument>   
  9.  (1998) CCD Latimer Watch 14 October 1998. An Interview with Gregor Wolbring Part I. In this interview, Dr. Wolbring analyzes the social context that has given rise to cases like Latimer and suggests a message that can be promoted to the media to counteract current stereotypes about disability
  10. (1998) CCD Latimer Watch 14 October 1998 Part II: Gregor Wolbring Rebuts the Compassion Argument

TV/ Radio appearances:

  1. Wolbring (2006) Korea Heart to Heart aired Dec. 5th 2006 Arirang TV station http://www.arirang.co.kr/Tv/Tv_Video_On.asp?PROG_CODE=TVCR0106&code=Po5&m_view_t=Vi&ptitle=
  2. Wolbring (2006) 3CR's Melbourne Radio Station October 2nd on Nanowater, disabled people and the second world water report. Interviewer Adam Beasley http://www.3cr.org.au/
  3. Wolbring (2005) CTV Interview Nov. 22nd  in Saskatchewan
  4. Wolbring (2005) DMT Interview Media and Technology Centre University of Saskatchewan
  5. Wolbring (2005) 3CR's Melbourne Radio Station July 14th on sustainability, new technologies and disabled people Interviewer Hannah Levit
  6.  Wolbring (2005) another interview with a Melbourne radio station July 13th interviewer Adam Beasley
  7.  Wolbring (2005) CKUT Montreal on Bioethics and disabled people to be aired Aug/Sept.
  8.  Wolbring (2004) TV Show Discovery Channel aired on August 08 in the TV show Medical Hot seat on the topic Thalidomide by Discovery Health Canada.
  9. Wolbring (2004) Human Enhancements: Is the Quest for Perfection Ethical? Hot Seat Guest: Simon Smith, founder and editor-in-chief of www.betterhumans.com, a Webzine that celebrates developments in life-extension and life-enhancement technologies. Panel Guests: Dr. Gregor Wolbring, a biochemist at the University of Calgary and a director of the International Centre for Bioethics, Culture and Disability; Rev. Canon Eric Beresford, ethics consultant for the Anglican Church of Canada and the Anglican Consultative Council. Another drug scandal rages in the world of professional sport – this time over the designer steroid known as THG. It is a reminder of just how far some people are willing to go to enhance their physical capabilities. Should we be free to use any and all technologies in the quest for human perfection? Or should we respect the limitations that nature has imposed? Vision TV http://www.visiontv.ca/HTML/Programs/CATestFaith.html
  10. Wolbring (2003) title: The Perfect Baby Subject: Is genetic testing morally wrong? Hot Seat: Professor Gregor Wolbring, a University of Calgary bioethicist whose mother took thalidomide. This is how vision TV describes it. But it was much more than that. I mostly debated James Hughes a transhumanist and it deals not just with genetics. http://www.visiontv.ca/HTML/Programs/InsightFaith2.html
  11. Wolbring (2003) Germany, Author Maike Dimar,  Radio Station Radio Z, z@radio-z.net, Production Date 26.06.2003, Date 25.06.2003/11:28,
  12. Wolbring (2002) Changesurfer radio From Disabled to Superman 07/22/2002  http://www.radio4all.net/proginfo.php?id=5062
  13. Wolbring (2002) Changesurfer radio Our Molecular Future Part 2 08/10/2002
  14. Wolbring (2002) Changesurfer radio And the Blind Shall See: Transhumanism, Eugenics and Disability Rights 09/21/2002 http://www.radio4all.net/proginfo.php?id=5400
  15. Wolbring (2002) CBC Radio One 9/4/02 THIS MORNING: On the Tuesday edition of This Morning...from Calgary, Shelagh Rogers speaks with Gregor Wolbring - prominent biochemist and bioethicist, and sought-after speaker. Wolbring was a thalidomide baby, born without legs, and is now an outspoken advocate for the disabled.
  16. Wolbring (2002) CBC the National a) website CBC.CA - The National Measuring up should genetic testing decide who is born? Airdate: March 11, 2002 Reporter: Alison Smith, Producer: Janet Thomson, b) written Transcripts 020311 c) real player video http://cbc.ca/news/national/real/smith_measuringup1.smil http://cbc.ca/news/national/real/smith_measuringup2.smil
  17. Wolbring (2002) Bob Carty, CBC Radio | January 2002 "Being Human: How medical technology is changing who we are" day three and six
  18. Cyborg Society / Bob Carty http://www.loe.org/shows/shows.htm?programID=02-P13-00023
  19. Wolbring (2002) CBC Ideas program Life, Death and Disability. http://radio.cbc.ca/programs/ideas/sounds/Disability1.rm
  20. (Wolbring 2002) ON A ROLL RADIO FOR MARCH 10, 2002: 6-7 PM Eastern Time: ELIMINATING DISABILITY? This week, we'll talk to Dr. Yuri Verlinsky who used genetic screening and in-vitro fertilization to create a child without the mother's gene for early-onset Alzheimer's disease.  Eliminating disability. Is this cool?  Gregor Wolbring, who has a disability, is a professor at the University of Calgary.  He'll express his reservations about biological engineering in people and in plants.  This is sure to be an interesting debate.  What do you think?  If science can eliminate the onset of certain disabilities, is this a good moral direction to move in?
  21. Wolbring (2001) 4th Sept. on TV3 (Kuala Lumpur Malaysia) regarding Disability and ICT
  22. Wolbring (2000) Ideas Program seminar Designing humans: Planning the perfect Gene Pool June 16.

Talks:

Talks to a mainly academic audience

  1.  Wolbring (2009) Ethical dimensions of enhancement, Gregor Wolbring;Marcus Düwell, Research School for Practical Philosophy, Utrecht, Netherlands; Judit Sandor Central European University Budapest , European Science Foundation LiU Conference Linköping, Sweden , Katrin Grüber , IMEW, GE; Ursula Naue, LSG, AU, YES, --,
  2. Wolbring (2009) October,  Ableism, Transhumanism and the transhumanization of Ableism: The Future has started today?, Gregor Wolbring, European Science Foundation-LiU Conference, Linköping, Sweden ,
  3. Wolbring (2009) May 24 Science and technology, disabled people and the meaning and space of country at Canadian Disability Studies association National Conference
  4. Wolbring (2009) April 14 Helen Gardiner class Mount Royal College, Calgary, Canada  
  5. Wolbring (2009) April 13 Pat Winters ethics class University of Calgary, Canada
  6. Wolbring (2009) April 11 “Human Beings—Sentient Beings: Species Typical, Sub-typical, and Beyond Typical” at American Philosophical Association Pacific Division Meeting, Vancouver, British Columbia
  7. Wolbring (2009) Artificial/Genetic Enhancement, Gregor Wolbring, MDSC 308, University of Calgary, Faculty of Medicine, Stan Godlovitch class, BHSc
  8. Wolbring (2009) March 20 Emerging Sciences and Technologies and Social Concepts and the Field of Rehabilitation at Leaders in Rehabilitation: The Rehabilitation of Function, The Function of Rehabilitation conference Edmonton, Canada
  9. Wolbring (2009) Feb 21 'Emerging sciences and technologies, transhumanism and rehabilitation identity', National Council of Rehabilitation Educators NCRE Annual Conference in San Antonio, TX
  10. Wolbring (2009) Feb 12 Ethics Round “Ableism and Ability Ethics and Governance: From Enhancement Medicine to Enhancement Rehabilitation” Alberta Health Services,and University of Calgary
  11. Wolbring (2009) Arizona State University January 14-16
  12. Wolbring (2008) January 9th, Lecture at the Disability Studies Retreat University of Minneapolis, USA Title: Why bother with Disability Studies
  13. Wolbring (2008)  January 22-24 CIHR Invitational Workshop on NELSI Nanotechnology
  14. Wolbring (2008)  January 22 invited Lecture in Puerto Rico at the university through Skype had to decline due to other engagement
  15. Wolbring (2008) March 3 Arizona State University USATalk to James Wetmore class
  16. Wolbring (2008) March 3rd March 3 Arizona State University USA to Bioethics group of Jason Roberts
  17. Wolbring (2008) March 3 Arizona State University USA InnovationSpace engineering and design students from Prasad Boradkar
  18. Wolbring (2008) March 4 March 3 Arizona State University USA talk to the math and cognition seminar series http://math.la.asu.edu/~tom/cognition/cognition.html
  19. Wolbring (2008) March 4 Arizona State University USA Talk to Sean Hays class
  20. Wolbring (2008) March 31st Calgary Pistorius: And Now? The Paralympics, the Olympics and Human Enhancement Technology, University of Calgary
  21.  Wolbring (2008) April 19 Calgary about back to work with an impairment/change in body functioning
  22. Wolbring (2008) April 23-25 Arizona State University USA
  23. Wolbring (2008) April 29th Calgary Genome Canada International conference talk on synthetic biology
  24. Wolbring (2008) May 27-28 Baltimore USA Tech 2025 event invited by National Security Agency, Signals Intelligence Directorate
  25. Wolbring (2008) June 12 Meeting in Edmonton of the What sorts of People group
  26. Wolbring (2008) June 13 Keynote speaker Alberta Health and Wellness Telehealth Unit Clinical Forum 2008 http://www.albertatelehealth.com/content.asp?category_id=87&root_id=87
  27. August 17-21 Gordon Conference USA Title: Ableism and new and emerging technologies
  28. Wolbring (2008) Sept. 21-26 Darmstadt Germany, Summer school on Ethics (and politics and metaphysics) of Converging Technologies
  29. Wolbring (2008) October 17 Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBICS and health research
  30.  Wolbring (2008) October 24 What Sorts of People meeting University of Alberta Edmonton
  31. Wolbring (2008) Oct 26-29 Arizona State University ·  Oct 27-Arizona State University10:00am – 11:45am – Nano and the Brain Project – Life Sciences E wing, room B52; 12:00 – 1:30pm – CET lunch – Memorial Union, Santa Cruz, #229 ; 2:00pm-3:00pm - Honours science and technology class CSPO conference room ; 3:05pm – 3:55pm – ASB 394 - Technology & Society class – College of Design North, Rm 68  Oct 28-Arizona State University 10:30am-11:45am - WSH 470 Women and Popular Culture in Discovery Hall 350; 12:00 – 1:30pm – Lunch with biological Design PhD students; 3:00pm – 4:15pm – CHM 501 - Science Policy for Scientists & Engineers – Interdisciplinary A, Room 111 ; 6:30pm – 8:00pm – Panel discussion with Jason Robert – Memorial Union, Ventana C Dean’s invitation  Oct 29-Arizona State University 10am – 11am – Meeting with Human and Social Dimensions of Science & Technology PhD Students – CSPO conference room; 1:30pm -2:45pm - Bioethics Club; 4:30pm-5:30pm- Neural Transhumanism: Technological challenges and ethical implications of neural engineering class;
  32. Wolbring (2008) Oct 31-2nd Nov Nanoethics meeting in Denmark (have been accepted with abstract but cancelled due to time problemsbut full paper was accepted)
  33. Wolbring (2008) Nov 7-8 MIT USA IGEM Jamboree  http://2008.igem.org/Main_Page Calgary Ethics Team
  34. Wolbring (2008) Nov 21-23 ASU
  35. Wolbring (2007) http://www.aclrc.com/OneOrigin/  November 15-17 Title New and emerging sciences and technologies and the social construction of boundaries
  36. Wolbring (2007) speaker at a conference 21-23 Nov Edmonton Canada Title New and emerging sciences and technologies and the Changing Way of Life
  37. Wolbring (2007) October 25-28 "The Revealed I" A conference on privacy and identity www.idtrail.org Faculty of Law, Ottawa, Canada on the panel invisibleI Marginalized persons long for one kind of privacy (freedom from unwanted surveillance) while suffering under another kind (a conspiracy of neglect).  This panel will investigate both aspects and include representatives of and advocates for some of Canada’s most vulnerable populations. My talk title very likely "Who decides who has a right to what cultural identity?" http://www.idtrail.org/content/section/11/95/
  38. Wolbring (2007) May 14-17 speaker at Converging technology meeting Vienna. Austria What Convergence is in the Cards for Future Scientists?
  39. Wolbring (2007) Talk at a preconference workshop University of Alberta April 27
  40. Wolbring  (2007) Talk at a meeting at Arizona State University April 20th
  41. Wolbring (2007) April 12  Lecture at the University of Minneapolis on new technologies
  42. Wolbring (2007) April 13 Lecture at the University of Minneapolis on the UN Convention on the Rights of persons with disabilities
  43. Wolbring (2007)  January 17 Lecture in Puerto Rico at the university on social and legal implication of new and emerging technologies (through webcam and Skype)
  44. Wolbring (2007) January 14  Lecture at University of Calgary Social Imagery and new and emerging technologies
  45. Wolbring (2006) Nov. 29 South Korea; Taegu university talk on policy implications of emerging technologies 
  46. Wolbring (2006) Nov. 25 South Korea Institute for the Integral Study of Life
  47. Wolbring (2006) Nov 14. University of Ottawa, Faculty of Law Torys Speakers Series Topic: Legal implications of emerging technologies;
  48. Wolbring (2006) University of Ottawa, Faculty of Law  a second talk Nov. 15 very likely on the legal implications of the UN Convention on the rights of persons with disabilities
  49. Wolbring (2006) October 30-31, Invited by the Office of the Chief Scientist and the Science Forum Organizing Committee to speak at the Annual Health Canada Science Forum, Ottawa, Ontario, Canada. Topic: The Impact of new and emerging technologies on health research and health policy
  50. Wolbring (2006)  October 24th Lecture to students from Prof. Hovey University of Calgary
  51. Wolbring (2006) October 12th Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBIC and health research
  52. Wolbring (2006) Sept 7 Talk Uof Calgary Faculty on Communication and culture Canada on Risk Discourse on emerging technologies Prof. Edna Einsiedel’s class
  53. Wolbring (2006) April 15th Lecture at University of Calgary Faculty of Medicine Title: Enhancement Medicine: The final frontier
  54. Wolbring (2006) What is the future of Nanomedicine, Chicago USA Nanotech meeting
  55. Wolbring (2006) What Standards? Nanostandard meeting in Michigan USA. Invited but can’t attend but take part through the net
  56. Wolbring (2006) Sept-20,What Next Forum, Uppsala Sweden Talk on Human Enhancement and Nanomedicine
  57. Wolbring(2006) Sept 22 Stockholm, Sweden, Lecture to Swedish Council on Technology Assessment in Health Care Topic: Impact of new and emerging technologies (Nanotech, biotech, infotech, cognitive sciences, synthetic biology) onto Evidence based Medicine and Health Technology Assessment  
  58. Wolbring (2006) Nanotechnology and marginalized groups at Vancouver Nano network Meeting
  59. Wolbring (2006) Meetings in Amsterdam, The Netherlands
  60. Wolbring (2006) Webtalk Enhancement medicine and Ableism with a UK conference held at University of Lancaster
  61. Wolbring (2006) Webtalk with University of Darmstadt Germany
  62. Wolbring (2006) Shad Valley talk Calgary Canada
  63. Wolbring (2006) The Enhancement Debate: Or Able-ism leads to transhumanism; lecture at University of Oxford, Said Business school, James Martin Institute for science and civilisation conference http://www.martininstitute.ox.ac.uk/jmi/forum2006/
  64. Wolbring (2006) 'Which Inequity matters' for a Science, Policy & Social Inequity Workshop at Arizona State University; http://www.cspo.org/home/events/inequityworkshoppapers.htm
  65. Wolbring (2006) Some Nano presentations at Arizona State University
  66. Wolbring (2006) The 2006 World Forum on Science and Civilization, 'Tomorrow's People: the Challenges of Technologies for Life Extension and Enhancement', talk on Enhancement Medicine
  67. Wolbring (2006) Guest lecture to a class taught by Carla Hamarsne. Enhancement Medicine
  68. Wolbring (2005) 23rd Nov Saskatoon Canada Lecture at the University
  69. Wolbring (2005) Oct. 5th Wednesday morning at 10:40- 11:30 freshman-level introduction to bioethics course, Arizona state university
  70. Wolbring (2005) Oct. 5th Wednesday afternoon Foundations of bioethics" course , a graduate intro to the topic, Arizona state university
  71. Wolbring (2005) October 5th Arizona state university. Bioethics in the Media
  72. Wolbring (2005) October 6th. Arizona state university Lecture:"Enhancement Medicine" www.cspo.org/projects/nanotechnology/ documents/asuEnhancementmedicinefinal%5B1%5D.ppt  
  73. Wolbring (2005) 12th Canadian Conference on International Health 6-9 November 2005, Ottawa. BIAS FREE Framework Workshop with Mary Anne Burke ( Global Forum for Health Research, Geneva) and Margit Eichler (OISE/UT)
  74. Wolbring (2005) 12th Canadian Conference on International Health 6-9 November 2005, Ottawa. Paper on TRANSHUMANISM, DISABLED PEOPLE AND GLOBAL HEALTH.
  75. Wolbring (2005) July 11th Melbourne Australia workshop on "How is sustainable human and non human development impacted by the governance of emerging technologies such as Nanotechnology, Biotechnology, Information technology and Cognitive Sciences; by the concept of health, disease, disability and well being and by biological diversity?" using realtime Webcam PC MSN Messenger video-capabilities
  76.  Wolbring (2005) July 13 Melbourne Australia workshop on the UN Decade of Education for sustainable development using realtime Webcam PC MSN Messenger video-capabilities
  77. Wolbring (2005) “Nanotechnology and the poor” for a meeting on Nanotechnology and the Poor in Alexandria, Egypt
  78. Wolbring (2005) ai05 Arts Intersection 2005: Art, Nature and Medicine. A Celebration of Interdisciplinary Exchange September 28, 2005 October 03, 2005 Trinity Western University Township of Langley, British Columbia, Canada.
  79. Wolbring (2004) "Disabled people, science and technology and health research" for Forum 8 of the Global forum of health research and the ministerial summit on health research organized by the World Health Organization and hosted by the Mexican Government. Mexico City, 16-20 November
  80. Wolbring (2004) "Research resource flow, new technologies and the 10/90 gap in health research" for Forum 8 of the Global forum of health research and the ministerial summit on health research organized by the World Health Organization and hosted by the Mexican Government. Mexico City, 16-20 November
  81. Wolbring (2004) “Social implications of the convergence of nano-scale technologies” For Nanodays 2004, Rice University, Houston, USA
  82. Wolbring (2004) "Confined to Your Legs: Self-Identity and the Nano-Bio-Info-Cogno-Technology Revolution” at Arizona State University USA
  83. Wolbring (2004) “Science and Governance, Living with the Genie PAF547 Science, Technology and Public Affairs” at Arizona State University, USA
  84. Wolbring (2004) guest lecture at Joann Williams IGERT Science and Society class, Arizona State University, USA
  85. Wolbring (2004) guest lecture Joan McGregor’s PHI/BIO 394 Bioethics class, Arizona State University, USA
  86. Wolbring (2004) Lunch Discussion with Bioethics Club, Arizona State University, USA
  87. Wolbring (2004) “Ethics and New Emerging Technologies” for Shad Valley students, Calgary, Canada
  88. Wolbring (2004) “Bioethics and disability” for Health Law Institute, University of Alberta, Edmonton Canada
  89. Wolbring (2004) "Disabled people science and technology and health research" for Community Health Dept Faculty of Medicine, University of Calgary, Canada
  90. Wolbring (2003) “Social justice/Human Genome and converging technologies” for University of Chicago, USA
  91. Wolbring (2003) “Euthanasia” for Faculty of Medicine, University of Calgary, Canada
  92. Wolbring (2003) “New Technologies” for Faculty of Medicine, University of Calgary, Canada
  93. Wolbring (2003) invited as an expert to a Workshop on Nanomedicine organized by SSERC http://www.regenerativemedicine.ca/nanomed/index-e.htm
  94. Wolbring (2003) invited as an expert to the workshop “Imperatives of Biotechnology in Health Innovation” organized by Health Canada
  95. Wolbring (2003) "Protecting Children and Decisionally-Impaired Adults in Biomedical and Behavioral Research: Is Bioethics Enough? Summer Ethics Institute National Catholic School of Social Service the Catholic University of America, Washington, DC
  96. Wolbring (2002) "What do we want from science and technology? How do scientific and technological changes influence the quality of our lives and mediate our ability to pursue "the good life"?” for the Conference Living with the Genie Columbia university, NYC, USA
  97. Wolbring (2002) "Bioethics and Disabled People: A Participatory Adventure" for the International Association of Public Participation Conference Re-Valuing Public Participation, Calgary, Alberta, Canada
  98. Wolbring (2002) “Disability rights and Science and Technology” for the Genetic and Disability conference organized by Health Canada
  99. Wolbring (2002) “Disability studies approach to bioethics” Kansai regional members of the disability studies and bioethics group in Kyoto, Japan
  100. Wolbring (2002) “Ethics and Disability” for Bioethics department, University of Bristol, UK
  101. Wolbring (2002) “Bioethics and Disability” for Health Ethic Centre, University of Alberta, Edmonton, Alberta, Canada
  102. Wolbring (2002) “Bioethics and Disability” for Mount Royal College, Calgary, Canada
  103. Wolbring (2002) “Science and Technology and the tyranny of normal”
    for the Canadian Association of Rehabilitation Professionals Conference, Ottawa, Canada
  104. Wolbring (2002) “Bioethics and disability” for research working group of Prof Ida (at that time president of the UNESCO International Bioethics Committee) Faculty of Law, Kyoto, Japan
  105. Wolbring (2002) “Why Scientist should get involved in the bioethics debate”
     for Faculty of Medicine, University of Kobe, Japan
  106. Wolbring (2002) “Disability perspective on genetics/diagnostics/therapy” at the Biotechnology and Society 200-level course run by Edna Einsiedel, Calgary, Canada
  107. Wolbring (2002) 2 Guest lectures at the disability studies dept. of Ryerson University, Toronto, Canada (Web cast)
  108. Wolbring (2001) "Disability in a Global Context Can we draw the Line? A Cross Cultural Perspective on Eugenics" for the Society for Disability Studies Annual conference Winnipeg, Canada
  109. Wolbring (2001) "Death making; Perception of Disability within the Debate of Bi/Gentechnology Issues” for the Society for Disability Studies Annual conference Winnipeg, Canada
  110. Wolbring (2001) "Bioethics and Disability" for the 4th Inter/National Undergraduate Bioethics Conference Emory University, Emory, USA
  111. Wolbring (2001) "Death and Dying" for the 4th Inter/National Undergraduate Bioethics Conference, Emory University Emory, USA
  112. Wolbring (2001) "Science Art and the Media" for the 4th Inter/National Undergraduate Bioethics Conference Emory University Emory, USA
  113. Wolbring and Silver (2001) “Bioethics and Disability workshop” at the AGM of the Provincial Health Ethic Network in Red Deer, Canada
  114. Wolbring (2001) Banff, Alberta, Canada Banff Centre of the Arts Conference title: Smart, Sexy and Healthy: This think tank gathers able bodied and disabled designers, theorists, researchers, health care practitioners, and technology developers, to explore the capabilities of networked and immersive technologies to educate, heal, redefine sensory perception and experience. Issues include: Diagnostics and technologies; Extended perceptions; Integration, Cultural Differences and Health in Networked contexts. What can we learn from those with different abilities? How can we use technology to imagine another's experience, communicate and heal? This is in close association with Dr. Gregor Wolbring, University of Calgary.
  115. Wolbring (2001) “Euthanasia Why? For whom? What safeguards?” for Bioethics week at the Foothills Hospital in Calgary, Canada
  116. Wolbring (2001) ‘Bioethics and Disability from Genetics to Euthanasia” for University of Illinois Chicago, USA
  117. Wolbring (2001) “Thalidomide: A Lesson Learned” for Mount Royal College Calgary, Canada
  118. Wolbring (2001) “Technology disability and perception” for Mount Royal College, women studies course, Calgary, Canada
  119. Wolbring (2001) “Inclusive Education” for Dept. of Education Government of Malaysia, Kuala Lumpur, Malaysia
  120. Wolbring (2001) “Bioethics and Disability” for Faculty of Medicine University of Kuala Lumpur, Kuala Lumpur, Malaysia
  121. Wolbring (2001) "Disabled people and ICT “for Multi Media Asia conference, Kuala Lumpur, Malaysia
  122. Wolbring (2001) “Biotechnology and ICT” for Multi Media Asia conference, Kuala Lumpur, Malaysia
  123. Wolbring (2001) "Genetics: New Paradigms" for National Science Center, Kuala Lumpur, Malaysia
  124. Wolbring (2001) "Bioethics the Law and disability" for Faculty of Law, University of Alberta, Edmonton, Canada
  125. Wolbring (2001) “Consequences of genetic diagnostic for disabled people” invited by the German Embassy in Washington, Washington DC, USA
  126. Wolbring (2001) invited as an expert to the Convergent Technologies (NBIC) for improving Human Performance Workshop organized by the National Science Foundation Washington DC, USA
  127. Wolbring (2000) Organizer of the Disability and Ethics session (Rachel Hurst (UK), Sigrid Graumann (Germany), Alison Brookes (Australia), Anita Silver (USA), and I) for the Fifth World Congress of Bioethics London UK. My talk at this session was called "Bioethical Issues and the Disabled"
  128. Wolbring (2000) "What NOW? The time after the sequencing of the human genome": for the "Genetics: New Paradigms" session: Tom Wilkie (Chair), Gregor Wolbring, Stefan Winter, Jan Hartman, Cynthia Cohen, and Francoise Baylis, Fifth World Congress of Bioethics London UK
  129. Wolbring (2000) “Bioethics and Disabled people” for the Solihull Conference on Bioethics by Disabled people International
  130. Wolbring (2000) on “Bioethik und Behinderung. Eine Einführung in die Nordamerikanische Bioethikdebatte aus der Perspective eines Akademikers/Aktivisten/Betroffenen”for Eberhard Karls University Tübingen Interdepartmental Center for Ethics in the Sciences and Humanities, Germany
  131. Wolbring (2000) “Indigenous people, disabled people and the biotech debate”   
    for the Institute of Indigenous Government, Vancouver, Canada 
  132. Wolbring (2000) “Science and the Disadvantaged; how can the UNESCO Declaration on Science and the use of Scientific Knowledge for the 21st Century be used in regards to disabled people” for The Millennium Symposium on Science, Society and Human Rights: Implementation of the UNESCO Declaration on Science and the use of Scientific Knowledge for the 21st Century, Regina, Canada
  133. Wolbring (2000) “The Ethics of Biotechnology and Euthanasia” for the Health Law Center’s perspectives program on disability issues in regards to Issues for a New Millennium, University of Alberta, Canada
  134. Wolbring (2000) “the implementation of the UNESCO World Conference on Sciences documents in the UK” for the Government Department of trade and industry, London, UK
  135. Wolbring (2000) “Bioethics and Disability” for Association of Rehabilitation Services, Calgary, Alberta
  136. Wolbring (2000) “Biotechnology, Health and Disability” for the Faculty of Nursing, University of Manitoba, Canada
  137. Wolbring (2000) “about the implementation of the UNESCO World Conference on Sciences documents and the inequality of the statement 'sex selection prohibition yes disability selection prohibition No'” for Faculty of Law, University of Alberta Edmonton, Canada
  138. Wolbring (1999) "Animal Farm Philosophy" for the 1999 Annual conference of the Canadian Bioethics Society
  139. Wolbring (1999) “the results of the muscular skeletal study” for the AGM of the Thalidomide Victims Association of Canada, Ottawa Canada on
  140. Wolbring (1999) “Bioethics, Disability and Equality rights: Is there a link between the three at Celebrating Diverse Approaches to Community Rehabilitations” for Pan Canadian Graduate Program Summer Institute, Calgary, Canada
  141. Wolbring (1998) "Is there a place for equality rights argument within the debate of bioethical issues" for the 1998 Annual conference of the Canadian Bioethics Society
  142. Wolbring (1998) “International Perspectives on Rehabilitation and Disability” for Pro Seminar for graduate studies of rehabilitation studies University of Calgary, Canada
  143. Wolbring (1996) “Euthanasia and Eugenics: why Disabled People are concerned”
    for Donald Beasley Institute Dunedin, New Zealand
  144. Wolbring (1996) “Challenges in Bio-Ethics” for Disability Centre Massey University, New Zealand
  145. Wolbring (1996) “Disability, Education and Ethics” for Auckland College of Education, New Zealand
  146. Wolbring (1994) “Disability Law and Society” for the Learned Conference, Calgary, Canada 

 

Talks to a mainly non-academic audience

 

  1. Wolbring (2008) December 4th United Way, Calgary UN Convention on the Rights of Persons with Disabilities: Dignity, Justice, Ableism and science and technologies
  2. Wolbring (2008) Nov 24-30 Monpellier France
  3. Wolbring (2008) October 17 Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBICS and health research
  4. Wolbring (2008) July 09 Presentation to Shad Valley students
  5. Wolbring (2008) June 3Calgary, Jewish Family Service Calgary on Disability Awareness/Culture
  6. Wolbring (2008) May 27-28 Baltimore USA Tech 2025 event invited by National Security Agency, Signals Intelligence Directorate
  7. Wolbring (2008) May 3rd Talk to highs chool kids on new and emerging technologies
  8. Wolbring (2008) May 3rd Talk with teachers about the consequences for them
  9. Wolbring (2008) April 14th, Washington DC, Bioethics Issues of Synthetic Biology
  10. Wolbring (2008) February 26-28 Talks and presentations at Alberta Health and Wellness on different aspects of new and emerging technologies
  11. Wolbring (2008) February 26-28 Presentation for Ecuadorian Constitution Commission related to the paper I wrote for them (Had to decline flying there due to Edmonton meeting. Paper available upon request).
  12. Wolbring (2008) AHFMR lecture at UofC to high school studends and teachers Title: TBD
  13. Wolbring (2007) December 3-7 Word Council of Churches world consultation on new and emerging technologies Johannesburg, South Africa
  14. Wolbring (2007) Nov 20 Lecture at "Leading Policy course at the Canada School of Public Service, Ottawa,Canada
  15. Wolbring (2007) October 16 Talk at the retreat of the Pharmaceuticals and Life Sciences section of Alberta Health and Wellness
  16. Wolbring (2007) October 12 Discovery Day presentation at University of Calgary
  17. Wolbring (2007) October 3-7 El Salvadore
  18. Wolbring (2007) September 5-12 Korea details to come
  19. Wolbring (2007) August 15 Presentation on Nanotechnology and Synthetic Biology to teachers and high school students organized by the Alberta Heritage Foundation for Medical Research
  20. Wolbring (2007) July 29-31 Planning committee meeting of the UN Millenium Project Minneapolis USA
  21. Wolbring (2007) July 11 Presentation to Shad Valley students
  22. Wolbring (2007) May 20  Speaker at National Down Syndrome Society annual conference *Emerging Technology and their impact on people with Down Syndrome//* From Stem cells to Nanotechnology to synthetic biology: What is in stock for health sciences and research and disabled people?
  23. Wolbring (2007) April 11 Cafe Scientifique  Bell Museum of Natural History Minneapolis Topic: Nanomedicine to Synthetic biology: What does it mean to be healthy?
  24. Wolbring (2006) Nov. 25 South Korea; Seminar at the Ministry of Education on the Future of Education 
  25. Wolbring (2006) Nov. 28 South Korea; Special Workshop for the members of the national Assembly of South Korea on the 10 most pressing and to be anticipated policy implications of emerging technologies 
  26. Wolbring (2006) NanoRegulation: For Whom, With Whom, By Whom, For What? conference talk also on the conference webpage hereAugust 9-10th Chicago USA
  27. Wolbring (2006) Resource person for the WorldBank online discussion on Natural Disaster and disabled people day 3 science and technology application
  28. July 27-29 Advisory team World report on Disability and Rehabilitation meeting on disability data and terminology, WHO,Geneva, Switzerland Talk KEY TERMINOLOGIES IN THE FIELD OF DISABILITY: Impact on data, rehabilitation ‘health services’ and disabled people"
  29. Wolbring (2006) July 25th  Theological Implications of new and emerging Technologies at the World Council of Churches, Geneva, Switzerland
  30. Wolbring (2006) July 14th Shad Valley talk Calgary Canada
  31. Wolbring (2006) Porto Alegre, Brazil, from 14-23 February 2006, 9th Assembly of the World Council of Churches  chair and talk at the  bioethics and disability session
  32. Wolbring (2006) Powerpoint, Canadian Agency for Drug and Technology for Health CADTH formerly CCOHTA Invitational Symposium http://www.cadth.ca/index.php/en/events/symposium-2006/speaker-presentations-daytwo http://www.cadth.ca/media/symposium_pdfs/cadth_symposium06_ppt_Wolbring.pdf  NBIC, /Enhancement-Medicine, Emerging technologies (Nano, Bio, Info, Cogno) and the Concept of Health: A New Challenge for HTA, Health Research, and Health Policy http://www.ccohta.ca/symposium/CCOHTA_Symposium_Program.html
  33. Wolbring (2006) Porto Alegre, Brazil, from 14-23 February 2006, 9th Assembly of the World Council of Churches talk at the ecumenical conversation on " New Technologies: Nano-technology and Genetic Engineering".
  34. Wolbring (2006) Talk to the Down Syndrome community in Sao Paulo 23-24th of February on Society and emerging technologies
  35. Wolbring (2006) 13 March Oxford, UK “Enhancement Medicine” to a group of NGO’s
  36. Wolbring (2006), May, Uppsala, Sweden on emerging technologies
  37. Wolbring (2006) July Health Technology Assessment Conference, Adelaide, Australia ??
  38. Wolbring (2006) 29 October to 2 November Cairo, may be Global Forum for Health Research ??
  39. Wolbring (2005) Conference on supported employment 23rd Nov Saskatoon Canada.
  40. Wolbring (2005) Sept17-23 Bossey Seminar, Switzerland. NBIC religion and faith.
  41. Wolbring (2005) May 2-6 Alberta Rehabilitation Conference Kananaskis:  Workshop on Bioethics and disability.
  42. Wolbring (2005) June 6th Geneva, Switzerland NBIC talk to the WCC (World Council of Churches)
  43. Wolbring (2005) June 7th Geneva, Switzerland NBIC talk to South Centre.
  44. Wolbring (2005) June 8th Geneva, Switzerland NBIC talk to UN agencies.
  45.  Wolbring (2005) January 26-January 30th Geneva Switzerland Global Forum for Health Research Meeting in regards to the 2005 Bangkok global conference on health promotion.
  46. Wolbring (2006) 9th World Down Syndrome Congress, Vancouver, British Columbia, Canada, from August 22 - 27, Topic to be determined.
  47. Wolbring (2004) “Confined to your legs self identity and the NBIC revolution” at Biodevastation conference San Francisco, USA.
  48. Wolbring (2004) “Bioethics and disability an overview” for the DPI World Summit 2004: Diversity Within Winnipeg, Canada.
  49. Wolbring (2004) “NBIC and marginalized groups” for World Council of Churches Genetic seminar, Geneva, Switzerland
  50. Wolbring (2004) Tech 20/20 event (prediction of social implication of technologies existing in 2020) invited by National Security Agency, Signals ++Intelligence Directorate; Baltimore, USA,
  51. Wolbring (2004) invited as an expert to the Roehrer Institute Pain and Suffering workshop Toronto, Canada
  52. Wolbring (2004) workshop on “Nanotechnology 101” for Biodevastation, San Francisco, USA
  53. Wolbring (20040 workshop on “Human enhancement” for Biodevastation, San Francisco, USA
  54. Wolbring (2004) workshop on “Disabled people and reproductive rights/genetics” for Biodevastation, San Francisco, USA
  55. Wolbring (2004) “Nano, Bio, Info, Cogno and human rights” for University of Alberta Health Law Institute Edmonton, Canada
  56. Wolbring (2004) “Introduction to Bioethics workshop” for Developmental Disabilities Resource Centre of Calgary on Calgary, Canada
  57. Wolbring (2003) Patient meets policy maker. Resource allocation in Health Care Meeting of the Charles Frosst Foundation for Health Care Banff Alberta Canada
  58. Wolbring (2003) "Disability angle on Nanotechnology" for Carbon versus Silicon: Thinking Small/ Thinking Fast Banff New Media Institute (BNMI), Canada
  59. Wolbring (2003) "NBIC, NGO's society and three types of disabled people" for WITHIN AND BEYOND THE LIMITS OF HUMAN NATURE - Working Conference on the Challenges of the New Human Genetic Technologies, Berlin, Germany
  60. Wolbring 2003) "The Right to be Different" for Ethik und Behinderung - ein Perspektivenwechsel" Öffentlicher Kongress, Berlin, Germany
  61. Wolbring (2002) numerous interventions at the November UNESCO International Bioethics Committee meeting \
  62. Wolbring (2002) on the panel A Biotech Future? With Vandana Shiva, David Suzuki, Nancy Olivieri at Biojustice conference, Toronto, Canada
  63. Wolbring (2002): "The Tyranny of “Normal: Disability, Culture & Human Engineering" for Biojustice Conference Toronto, Canada
  64. Wolbring (2002) "Bioethics and genetic discrimination" for the 6th Assembly of Disabled people International Sapporo, Japan
  65. Wolbring (2002) "Bioethics and quality of life assessment" for the 6th Assembly of Disabled people International Sapporo, Japan
  66. Wolbring (2002) "Bioethics and who makes the decisions" for the 6th Assembly of Disabled people International Sapporo, Japan
  67. Wolbring (2002), “Why being an advocate?” for Youth Advocacy Conference organized by the Council of Canadians with Disabilities, Winnipeg, Canada
  68. Wolbring (2002) “Human Performance Enhancement: a different perspective” for Biowatch, Cape Town, South Africa
  69. Wolbring (2002), “A disability rights approach to the governance of science and technology; NBIC (Nano-Bio-Info-Cogno tech) threatening the self determination of disabled people” for Biowatch, Cape Town, South Africa
  70. Wolbring (2002), “Genetic Engineering: from designer plants to designer humans: Disability Rights and Bio-Medicine” for Food Action, Ottawa, Canada
  71. Wolbring (2001) “Pride versus Prejudice” for a disability conference Kuala Lumpur, Malaysia
  72. Wolbring (2001), “Farmers and Disabled people; Two peas in a pod” for a public event organized by the Genetic Engineering Activist Network, Chicago, USA
  73. Wolbring (2001), “Disability perspective on Biocommerce” at the Genetic Engineering Activist Network conference on a Biocommerce panel, Chicago, USA
  74. Wolbring (2001), “Euthanasia: Why? For Whom? What safeguards?” for the Unitarian Church Calgary, Canada
  75. Wolbring (2001), “Disability perception of the Biotech critique movement and impact of gene technology on disabled people” for the Doug Hammarskjöld foundation Uppsala, Sweden
  76. Wolbring (2001), “Genetics and Disability” Humanist Meeting, Calgary, Canada
  77. Wolbring (2001) workshop: "New Technologies: Options e Impositions" Hotel Terraverde, Temuco, Chile. I covered the bioethics and disability part
  78. Wolbring (2000) “Bioethics and Human Rights” for A MILLENNIUM CONFERENCE organized by Disabled People’s International Europe,
  79. Wolbring (2000) “For Whose Benefit? Biomedical Research- Biomedical, pharmaceuticals, genetic screening, human genome project” for the Biotechnology, Big Money Bad Science conference in Vancouver, Canada http://www.radio4all.org/unwelcome/archive26-50.html  Show 36 hour 2,
  80. Wolbring (2000) “Genetics Eugenics, Animal Farm Philosophy and disability” for 4th Biodevastation conference, Boston, USAWolbring (2000)
  81. “Disability and genetics” for the AGM of the Little People of America, Minneapolis, USA
  82. Wolbring (2000) “The REAL tragedy of thalidomide" for Unitarian Church of Calgary” Canada
  83. Wolbring (2000) “Commodification of being; being a piece of art; transhumanism the final solution of Eugenics” for Growing Things: The Cultures of Nano Tech, Bio Tech, and Eco Tech Meat Art,   Banff Arts Centre, Canada, section Genetic Engineering, Aesthetics: Culture listen to presentation (36:01) http://www.banffcentre.ca/bnmi/programs/archives/2000/growing_things/listen.aspx
  84. Wolbring (2000) at International Human Rights Day Calgary, Canada
  85. Wolbring (2000) “Euthanasia, how it effects the Disabled” for the Euthanasia Symposium organized by the Euthanasia Prevention Coalition of Ontario, Canada
  86. Wolbring (2000) Workshop “The Anti Biotech and the disability movement where do they collide what do they have in common” for the 4th Biodevastation conference Boston, USA,
  87. Wolbring (2000) and Newell (200) workshop on "Is it Proper Knowledge? Facilitating the Disability Perspective in Bioethics” for “A MILLENNIUM CONFERENCE,” by Disabled People’s International Europe, Solihull. UK
  88. Wolbring (2000) workshop on “Bioethics and Disability” for the Council of Canadians with Disabilities in Winnipeg, Canada
  89. Wolbring (2000) “Bioethics and Disability” for Canadian Institute on Disability studies
  90. Wolbring (2000) 12:30-4 p.m. Video and talk on human rights implications of genetic engineering, with Dr. G. Wolbring. At Sandy Hill Community Health Centre, 221 Nelson St. Call Food Action Ottawa.
  91. Wolbring (2000) Workshop on Implementation of the UNESCO Declaration on Science and the use of Scientific Knowledge for the 21st Century and it's importance for the Canadian Advocacy Scene for the Council of Canadians with Disability, Winnipeg, Canada
  92. Wolbring (1999) “The human/equality/disability rights within bioethical issues” in BUDAPEST, HUNGARY
  93. Wolbring (1999) “Bioethics philosophies and independent living philosophies where do they collide” in BUDAPEST, HUNGARY
  94. Wolbring (1999), “Animal Farm Philosophy: The genetic revolution and the end of human rights” for the meeting organized by Southern Alberta Council on Public Affairs Lethbridge, Canada
  95. Wolbring (1998) “Con Euthanasia” for the Nose Hill Parliament Calgary, Canada
  96. Wolbring (1998) assisted Suicide & Safeguards Workshop by BC Coalition of People with Disabilities
  97. Wolbring (1997) presentation to the Canadian Commission for UNESCO on the “UNESCO Declaration on the Human Genome and human rights
  98. Wolbring (1997) Workshops for the Board of Directors of the Council of Canadians with Disabilities on the “Eugenic use of new reproductive technologies and genetics”
  99. Wolbring (1996) “Medical Ethics and the Law” for the CACL National Conference Winnipeg Canada
  100. Wolbring (1994) “Do the disabled deserve to be born?” for the Association for Awareness and Accessibility, Calgary, Canada

 

Presentation to the Parliament of Canada

  1. Wolbring (1997) Presentation to the Sub-Committee on Health investigating public concerns about Bill C-47 http://www.parl.gc.ca/committees352/srta/evidence/06_97-04-09/srta06_blk101.html
  2. Wolbring (1997) Presentation to the Standing Committee on Human Rights and the Status of Persons with Disabilities on the issue of Privacy Rights and New technologies
  3. Wolbring (1996) Presentation to the Standing Committee on Human Rights and the Status of Persons with Disabilities on the issue of New technologies and Human rights

Youth-related activities:

  1. Wolbring (2008) October 17 Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBICS and health research
  2. Wolbring (2008) July xx Presentation to Shad Valley students
  3. Wolbring (2007) October 12 Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBICS and health research
  4. Wolbring (2007) August 15 AHFMR lecture at UofC to high school studends and teachers Title: "From Nanotechnology to Synthetic Biology: Cool Science, Cool Products and Potentially Not So Cool Side Effects"
  5. Wolbring (2007) July 11 Presentation to Shad Valley students
  6. Wolbring (2006) Talks to Shad Valley student for a few years now. Last so far 2006. Anticipated to give again talk in 2007 and years to come
  7. Wolbring (2006) October 12th Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary talk on NBIC and health research to high school students
  8. Wolbring (2006) October 12th Canadian Medical Hall of Fame/Pfizer Canada Discovery Day in Health Sciences University of Calgary workshop on  Bioethics  with high school students
  9. Wolbring (2005-)He is a member of the Canadian Commission for UNESCO  Associated Schools Project Network (ASPNet)
  10. Wolbring (2004-) Listed as a resource person by the Alberta Teachers' Association http://www.teachers.ab.ca/diversity/Resources/Resources.htm
  11. Wolbring (2002-)  Moderator of the youth listserve of the Canadian Commission for UNESCO
  12. Wolbring (2004) Mühlhausen Germany, lecture on genetics and disability to a high school class
  13. Wolbring (2003) Member of the Jury for the National Science Fair, (high school students), Calgary
  14. Wolbring (2003) Berlin Int. high school student symposium organized by the German UNESCO school project
  15. Involved with the UNESCO Associated Schools Project Network (ASPnet) in Canada

Other:

  1. Wolbring (2005) November 19 & 20, 2005:"Picture This....Film Festival" jury
  2. Wolbring (2004) Calgary Canada Disability Film Festival
  3. Wolbring (2003) Jury duty for the Disability Film Festival Calgary, Canada
  4. Wolbring (2002) Jury duty for the Disability Film Festival Calgary, Canada
  5. Wolbring (1991) Initiator and Member, Steering committee of the first world congress of thalidomiders which was held in the Netherlands in 1992
  6. Wolbring (1991) Initiator of- and Advisor to the British Broadcasting Corporation's disability program "One in Four" England on a program dealing with A) the holocaust of disabled people during the Nazi times and B) how bioethical issues are affecting disabled people

Search engine hits for “Gregor Wolbring”/Wolbring:

  1. Yahoo 1540/8260
  2. Google 14,900/43000
  3. AltaVista 1530/8220
  4. Windows Live Search 2333/5487
  5. HotBot 1070/1690

 

Consultant for:

  1. Science & Technology Foresight directorate of the Office of the National Science Advisor, Government of Canada
  2. Pharmaceuticals and Life Sciences section of Alberta Health and Wellness
  3. Study Commission on the Law and Ethics of Modern Medicine of the German Bundestag
  4. World Council of Churches
  5. Disabled People International World Summit
  6. Global Forum for Health Research, Geneva Switzerland

Biochemistry related Career:

 

Publications in Biochemistry

  1. Schafer PH, Gandhi AK, Loveland MA, Chen RS, Man HW, Schnetkamp PP, Wolbring G, Govinda S, Corral LG, Payvandi F, Muller GW, Stirling DI. Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs. J Pharmacol Exp Ther. 2003 Mar 20 [epub ahead of print] PMID: 12649301 [PubMed - as supplied by publisher]
  2. Wolbring, G., and Schnetkamp, P.P.M. Methods in Enzymology Vol. 315, 2000 Spectrophotometric Determination of Retinal Rod Guanylyl Cyclase page 718-728
  3. Lachance, M., Ethier, N., Wolbring, G., Schnetkamp, P.P.M., and Hebert, T.E. 1999, Stable association of G proteins with b2AR is independent of the state of receptor activation. 1999, Cell. Signal. Vol.11 No.7, pp. 523-533
  4. Wolbring G., Baehr W., Palczewski K., and Schnetkamp PP Light inhibition of bovine retinal rod guanylyl cyclase mediated by beta gamma-transducin. In Biochemistry 1999 Mar 2; 38(9):2611-6
  5. Wolbring G., Schnetkamp P.P.M. Modulation of the calcium sensitivity of bovine retinal rod outer segment guanylyl cyclase by sodium ions and protein kinase A. in Biochemistry 1996 Aug 27; 35(34):11013-8
  6. Wolbring G., Schnetkamp P.P.M. Activation by PKC of the Ca(2+)-sensitive guanylyl cyclase in bovine retinal rod outer segments measured with an optical assay in Biochemistry 1995 Apr 11;34(14):4689-95
  7. Wolbring G., Hollenberg M.D., Schnetkamp P.P.M. Inhibition of GTP-utilizing enzymes by tyrphostins in Journal of Biological Chemistry 1994 Sep 9; 269(36):22470-2
  8. Wolbring G., Cook N.J. Rapid purification and characterization of protein kinase C from bovine retinal rod outer segments in European Journal of Biochemistry 1991 Nov 1; 201(3):601-6
  9. Friedel U., Wolbring G., Wohlfart P., Cook N.J. The sodium-calcium exchanger of bovine rod photoreceptors: K(+)-dependence of the purified and reconstituted protein in Biochimica et Biophysica Acta 1991 Jan 30;1061(2):247-52

Awards:

Biochemistry

  1. Ph.D. fellowship of the Axel Springer Foundation, Germany 1989-1992;
  2. Post-Doctoral Fellowship of the Foundation for the advancement of highly gifted disabled people, Vaduz, Liechtenstein 1992-1994; 
  3. Post Doctoral Fellowship of the retinitis pigmentosa foundation of Canada 1994- 1996;
  4. Post Doctoral Fellowship of the retinitis pigmentosa foundation of Canada 1997 (the 1997 was a new competition not a renewal of the 1994-1996 award);
  5. Operating grant from Celgene (a USA pharmaceutical company) 1998- 2000;
  6. Operating grant from Celgene for 2000- 2003;
  7. Operating grant from Celgene for 2003- 2006;
  8. Operating grant from Celgene for 2006-2008